How Expensive Is Wegovy in the UK — and What Drives the Cost?

What the UK private market actually charges for semaglutide

Wegovy's cost in the UK private market isn't fixed, it moves with dose, with demand and with manufacturer pricing decisions. The reported range for private semaglutide treatment has broadly been £149 to £375 a month, with lower doses at the cheaper end during the slow titration phase and higher maintenance doses at the top. To check roughly where any provider sits, spend sixty seconds on their website adding the maintenance-dose pen to a hypothetical consultation and reading what's itemised at checkout, that breakdown tells you more than the headline figure.

It is worth knowing why costs rose noticeably through 2025. Eli Lilly's September 2025 list-price increase for Mounjaro pushed the broader GLP-1 market upward, including semaglutide pricing from some providers, because the competitive anchor shifted. None of this makes Wegovy inexpensive; it has never been. What's changed is the floor.

For those who find the monthly cost hard to plan around, the range of licensed weight-loss treatments available privately includes options at different price points, and a prescriber can discuss which may suit your situation.

What a Wegovy price quote should include, and what it sometimes leaves out

A legitimate Wegovy price covers more than the pen. Prescription-only medicines require a prescriber to review your health history and issue an individual prescription; that clinical work has a cost, and providers handle it differently. Some charge a flat consultation fee on top of the medicine price. Others wrap the assessment, prescription, delivery and any dose-change reviews into one figure. Neither model is automatically better, but you can only compare quotes fairly if you know which model you're looking at.

Delivery charges add up too. A service that posts Wegovy in untracked plain packaging is a different proposition from one with next-working-day tracked delivery. Aftercare matters as well: a prescriber who reviews your progress before every repeat order and is reachable seven days a week is genuinely providing more than one who issues a prescription and disappears. When people describe semaglutide as feeling expensive relative to the support they received, it's often the aftercare gap they're describing.

At nume, one price covers the consultation, prescription, delivery and ongoing clinical review, no add-ons, no subscription. Our clinical oversight is described on the about us page for anyone who wants to understand how it works before committing to anything.

NHS access to Wegovy: the honest picture

NICE recommended semaglutide for weight management (TA875) for adults who meet specific criteria: a BMI of 35 or above alongside at least one weight-related health condition, used within a specialist multidisciplinary weight management service, for a maximum of two years. Lower BMI thresholds apply for some ethnic backgrounds under the same guidance. That sounds straightforward; the practical reality is that access is tightly rationed through specialist services with significant waiting times in most areas.

If you meet those criteria and are prepared to wait, the NHS route is free. If you don't meet them, or you'd rather not wait, a regulated private pharmacy is the legal alternative, and the process for accessing Wegovy privately is more straightforward than many people expect. What it is not, legally, is something you can obtain without a proper clinical assessment, regardless of what price is advertised.

The NICE appraisal of semaglutide (TA875) sets out the eligibility criteria in full if you want to read the exact commissioning language.

Is Wegovy too expensive to be worth it, how to think about the question

Whether Wegovy is too expensive is genuinely a personal financial question, and there is no useful answer that pretends otherwise. What clinical evidence does show is that semaglutide produces meaningful average weight reduction over time: in the STEP 1 trial (68 weeks, 2.4mg semaglutide versus placebo) average body weight fell by around 15% in participants receiving semaglutide, as reported in the New England Journal of Medicine. For some people, that changes health outcomes enough to shift how they think about the monthly cost.

For others, it is genuinely prohibitive. That's a legitimate response. Comparing how Wegovy's price sits relative to other semaglutide products is one way to think through the options, as is discussing with a prescriber whether a different licensed medicine might be clinically appropriate. The question of cost is a real one; the answer should come from an honest assessment of what the treatment is, what it includes, and what outcomes the evidence supports, not from the cheapest listing on a search results page.

If you'd like to talk through what private treatment actually involves before making any decision, our prescribers are the right starting point, and if you want to understand the practical side of using the medication, our guide on how to give Wegovy walks through the injection process clearly. You may also find it helpful to know that some people experience digestive side effects such as excessive gas on Wegovy, which is worth being aware of before you begin. For anyone curious about the background of the treatment, how old Wegovy is as an approved medicine gives useful context on where it sits in the development of GLP-1 therapies. Speak to our prescribers through a free consultation, no obligation to proceed.